Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Nivolumab plus cabozantinib versus sunitinib in first-line treatment for advanced renal cell carcinoma (CheckMate 9ER): long-term follow-up results from an open-label, randomised, phase 3 trial.
Motzer RJ, Powles T, Burotto M, Escudier B, Bourlon MT, Shah AY, Suárez C, Hamzaj A, Porta C, Hocking CM, Kessler ER, Gurney H, Tomita Y, Bedke J, Zhang J, Simsek B, Scheffold C, Apolo AB, Choueiri TK. Motzer RJ, et al. Among authors: hocking cm. Lancet Oncol. 2022 Jul;23(7):888-898. doi: 10.1016/S1470-2045(22)00290-X. Epub 2022 Jun 7. Lancet Oncol. 2022. PMID: 35688173 Free PMC article. Clinical Trial.
Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma.
Choueiri TK, Powles T, Burotto M, Escudier B, Bourlon MT, Zurawski B, Oyervides Juárez VM, Hsieh JJ, Basso U, Shah AY, Suárez C, Hamzaj A, Goh JC, Barrios C, Richardet M, Porta C, Kowalyszyn R, Feregrino JP, Żołnierek J, Pook D, Kessler ER, Tomita Y, Mizuno R, Bedke J, Zhang J, Maurer MA, Simsek B, Ejzykowicz F, Schwab GM, Apolo AB, Motzer RJ; CheckMate 9ER Investigators. Choueiri TK, et al. N Engl J Med. 2021 Mar 4;384(9):829-841. doi: 10.1056/NEJMoa2026982. N Engl J Med. 2021. PMID: 33657295 Free PMC article. Clinical Trial.
Characterization of Patients With Metastatic Renal Cell Carcinoma Experiencing Complete Response to First-line Therapies: Results From the International Metastatic Renal Cell Carcinoma Database Consortium.
Takemura K, Navani V, Ernst MS, Wells JC, Meza L, Pal SK, Lee JL, Li H, Agarwal N, Alva AS, Hansen AR, Basappa NS, Szabados B, Powles T, Tran B, Hocking CM, Beuselinck B, Yuasa T, Choueiri TK, Heng DYC. Takemura K, et al. Among authors: hocking cm. J Urol. 2023 Apr;209(4):701-709. doi: 10.1097/JU.0000000000003132. Epub 2022 Dec 27. J Urol. 2023. PMID: 36573926
Panitumumab in metastatic colorectal cancer.
Hocking CM, Townsend AR, Price TJ. Hocking CM, et al. Expert Rev Anticancer Ther. 2013 Jul;13(7):781-93. doi: 10.1586/14737140.2013.811064. Epub 2013 Jun 26. Expert Rev Anticancer Ther. 2013. PMID: 23802848 Review.
COVID-19 infection among patients with cancer in Australia from 2020 to 2022: a national multicentre cohort study.
Hall VG, Sim BZ, Lim C, Hocking C, Teo T, Runnegar N, Boan P, Heath CH, Rainey N, Lyle M, Steer C, Liu E, Doig C, Drummond K, Charles PGP, See K, Lim LL, Shum O, Bak N, Mclachlan SA, Singh KP, Laundy N, Gallagher J, Stewart M, Saunders NR, Klimevski E, Demajo J, Reynolds G, Thursky KA, Worth LJ, Spelman T, Yong MK, Slavin MA, Teh BW. Hall VG, et al. Lancet Reg Health West Pac. 2023 Jun 19;38:100824. doi: 10.1016/j.lanwpc.2023.100824. Online ahead of print. Lancet Reg Health West Pac. 2023. PMID: 37360862 Free PMC article.
Can we accurately report PTEN status in advanced colorectal cancer?
Hocking C, Hardingham JE, Broadbridge V, Wrin J, Townsend AR, Tebbutt N, Cooper J, Ruszkiewicz A, Lee C, Price TJ. Hocking C, et al. BMC Cancer. 2014 Feb 25;14:128. doi: 10.1186/1471-2407-14-128. BMC Cancer. 2014. PMID: 24564252 Free PMC article. Clinical Trial.
13 results